Literature DB >> 17447000

Modulation of antidepressant-like activity of magnesium by serotonergic system.

E Poleszak1.   

Abstract

The influence of magnesium on the action of antidepressants drugs with different pharmacological profiles citalopram, reboxetine and tianeptine, was investigated in the forced swim test (FST) in mice. Magnesium (10 mg Mg/kg) given with reboxetine (2.5 mg/kg) did not change the behavior of animals in the FST. A synergistic effect was seen when magnesium (10 mg Mg/kg) was given jointly with citalopram (15 mg/kg) or tianeptine (20 mg/kg) in the FST, without accompanying changes in locomotor activity. Moreover, the antidepressant-like effect of magnesium (30 mg Mg/kg) was significantly reduced by pretreatment of mice with an inhibitor of serotonin synthesis, p-chlorophenylalanine (pCPA, 200 mg/kg). Thus, the antidepressant-like action of magnesium in the FST seems to involve an interaction with serotonergic system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447000     DOI: 10.1007/s00702-007-0714-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  56 in total

1.  Plasma magnesium and calcium in depression.

Authors:  D Frizel; A Coppen; V Marks
Journal:  Br J Psychiatry       Date:  1969-12       Impact factor: 9.319

Review 2.  Tianeptine: a review of its use in depressive disorders.

Authors:  A J Wagstaff; D Ormrod; C M Spencer
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.

Authors:  G Nowak; R Trullas; R T Layer; P Skolnick; I A Paul
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

4.  Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms.

Authors:  J Linder; K Brismar; J Beck-Friis; J Sääf; L Wetterberg
Journal:  Acta Psychiatr Scand       Date:  1989-12       Impact factor: 6.392

5.  An analysis of hypermagnesemia and hypomagnesemia.

Authors:  N Hashizume; M Mori
Journal:  Jpn J Med       Date:  1990 Jul-Aug

6.  Effects of acute and chronic treatment with magnesium in the forced swim test in rats.

Authors:  Ewa Poleszak; Piotr Wlaź; Ewa Kedzierska; Maria Radziwon-Zaleska; Andrzej Pilc; Sylwia Fidecka; Gabriel Nowak
Journal:  Pharmacol Rep       Date:  2005 Sep-Oct       Impact factor: 3.024

Review 7.  Mechanisms contributing to antidepressant zinc actions.

Authors:  Gabriel Nowak; Bernadeta Szewczyk
Journal:  Pol J Pharmacol       Date:  2002 Nov-Dec

8.  Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel.

Authors:  H Mori; H Masaki; T Yamakura; M Mishina
Journal:  Nature       Date:  1992-08-20       Impact factor: 49.962

9.  Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.

Authors:  W Löscher; R Annies; D Hönack
Journal:  Eur J Pharmacol       Date:  1993-10-05       Impact factor: 4.432

10.  The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats.

Authors:  W Löscher; R Annies; D Hönack
Journal:  Neurosci Lett       Date:  1991-07-22       Impact factor: 3.046

View more
  6 in total

1.  Magnesium treatment palliates noise-induced behavioral deficits by normalizing DAergic and 5-HTergic metabolism in adult male rats.

Authors:  Saida Haider; Sadia Sadir; Fizza Naqvi; Zehra Batool; Saiqa Tabassum; Saima Khaliq; Lubna Anis; Irfan Sajid; Darakhshan J Haleem
Journal:  Metab Brain Dis       Date:  2016-03-01       Impact factor: 3.584

2.  A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice.

Authors:  Ewa Poleszak; Piotr Wlaź; Bernadeta Szewczyk; Aleksandra Wlaź; Regina Kasperek; Andrzej Wróbel; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2011-04-02       Impact factor: 3.575

3.  Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice.

Authors:  Anna Serefko; Aleksandra Szopa; Aleksandra Wlaź; Sylwia Wośko; Piotr Wlaź; Ewa Poleszak
Journal:  J Neural Transm (Vienna)       Date:  2015-10-28       Impact factor: 3.575

4.  DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests.

Authors:  Aleksandra Szopa; Ewa Poleszak; Karolina Bogatko; Elżbieta Wyska; Sylwia Wośko; Urszula Doboszewska; Katarzyna Świąder; Aleksandra Wlaź; Jarosław Dudka; Andrzej Wróbel; Piotr Wlaź; Anna Serefko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-09       Impact factor: 3.000

Review 5.  Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications.

Authors:  Jessica Wang; Phoebe Um; Barbra A Dickerman; Jianghong Liu
Journal:  Nutrients       Date:  2018-05-09       Impact factor: 5.717

6.  Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.

Authors:  Beata Ryszewska-Pokraśniewicz; Anna Mach; Michał Skalski; Piotr Januszko; Zbigniew M Wawrzyniak; Ewa Poleszak; Gabriel Nowak; Andrzej Pilc; Maria Radziwoń-Zaleska
Journal:  Nutrients       Date:  2018-08-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.